Zeo ScientifiX, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
3321 COLLEGE AVENUE, DAVIE, FL, 33314
Mailing Address
3321 COLLEGE AVENUE, DAVIE, FL, 33314
Phone
888-963-7881
Fiscal Year End
1031
EIN
474180540
Financial Overview
FY2024
-$4.71M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 10-Q Quarterly financial report | March 17, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 6, 2026 | View on SEC |
| 3 Initial insider ownership report | February 6, 2026 | View on SEC |
| 10-K Annual financial report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| 8-K Current report of material events | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
Annual Reports
10-K
January 29, 2026
- Clinical-stage biopharmaceutical company focused on innovative biological treatments for degenerative diseases and regenerative medicine.
- Develops products from ethically sourced birth tissue, including two main candidates: Zofin™ and Patient Pure X™ (PPX™).
Material Events
8-K
Leadership Change
January 5, 2026
Medium Impact
- Ian T. Bothwell has been officially appointed as the full-time Chief Executive Officer (CEO) of Zeo ScientifiX, Inc.
- Bothwell will continue to serve in his existing role as Chief Financial Officer (CFO), holding both key positions.
Related Companies
Companies in the same industry (SIC: 2836)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.